FUNDAMENTALS · Fundamentals · US Industrials

Ultralife (ULBI) Fundamentals 2026 — Revenue Analysis | SniperIQ

Ultralife (ULBI) is a US-listed Industrials company in Electrical Equipment & Parts with a market capitalization of $90M, trading at $5.42 on the NASDAQ. This SniperIQ fundamentals page covers Ultralife's valuation, profitability (net margin -4.4%), revenue (

91M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$90M
Net Margin-4.4%
Revenue (FY25)
91M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Ultralife's market cap?

Ultralife (ULBI) has a market capitalization of approximately $90M, trading at $5.42 on the NASDAQ. Market cap moves with the live share price.

What is Ultralife's P/E ratio?

Ultralife's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.

How profitable is Ultralife?

Ultralife runs a net profit margin of -4.4%, a gross margin of 22.4%, and an operating margin of 2.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Ultralife generate?

Ultralife reported revenue of

91M for fiscal year 2025, with net income of -$6M and earnings per share (EPS) of -0.35. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Ultralife pay a dividend?

Ultralife does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Ultralife financially healthy?

Ultralife carries a debt-to-equity ratio of 0.37x and a current ratio of 2.56x, with a market beta of 0.78. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Ultralife a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ultralife (ULBI) the key facts are: market cap $90M, revenue

91M, 52-week range 4.9-9.19. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.

Track Ultralife's full fundamentals live

Get Ultralife's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Arq (ARQ) fundamentals · Surf Air Mobility (SRFM) fundamentals · TAS Offshore (5149) fundamentals · One and one Green Technologies (YDDL) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons